Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

about

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

Item

http://www.wikidata.org/entity/Q48170687

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

@en

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

@nl

type

Item

label

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

@en

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

@nl

prefLabel

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

@en

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

@nl

P1476

Genetic landscape of clear cell endometrial cancer and the era of precision medicine

@en

P2093

Alessandro D Santin

http://www.w3.org/2001/XMLSchema#string

Gloria S Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response

TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Integrated genomic characterization of endometrial carcinoma

A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress.

TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.

Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge.

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

P304

3216-3218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/CNCR.30743

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Gloria S Huang

Alessandro D Santin

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485840

http://www.w3.org/2001/XMLSchema#string

P932

5907932

http://www.w3.org/2001/XMLSchema#string